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Abstract
Background: Reading and language skills have overlapping genetic bases, most of which are still unknown. Part of
the missing heritability may be caused by copy number variants (CNVs).
Methods: In a dataset of children recruited for a history of reading disability (RD, also known as dyslexia) or
attention deficit hyperactivity disorder (ADHD) and their siblings, we investigated the effects of CNVs on reading
and language performance. First, we called CNVs with PennCNV using signal intensity data from Illumina
OmniExpress arrays (~723,000 probes). Then, we computed the correlation between measures of CNV genomic
burden and the first principal component (PC) score derived from several continuous reading and language traits,
both before and after adjustment for performance IQ. Finally, we screened the genome, probe-by-probe, for
association with the PC scores, through two complementary analyses: we tested a binary CNV state assigned for
the location of each probe (i.e., CNV+ or CNV−), and we analyzed continuous probe intensity data using FamCNV.
Results: No significant correlation was found between measures of CNV burden and PC scores, and no
genome-wide significant associations were detected in probe-by-probe screening. Nominally significant
associations were detected (p~10−2–10−3) within CNTN4 (contactin 4) and CTNNA3 (catenin alpha 3). These
genes encode cell adhesion molecules with a likely role in neuronal development, and they have been
previously implicated in autism and other neurodevelopmental disorders. A further, targeted assessment of
candidate CNV regions revealed associations with the PC score (p~0.026–0.045) within CHRNA7 (cholinergic
nicotinic receptor alpha 7), which encodes a ligand-gated ion channel and has also been implicated in
neurodevelopmental conditions and language impairment. FamCNV analysis detected a region of association
(p~10−2–10−4) within a frequent deletion ~6 kb downstream of ZNF737 (zinc finger protein 737, uncharacterized
protein), which was also observed in the association analysis using CNV calls.
Conclusions: These data suggest that CNVs do not underlie a substantial proportion of variance in reading and
language skills. Analysis of additional, larger datasets is warranted to further assess the potential effects that we found
and to increase the power to detect CNV effects on reading and language.
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Background
Reading disability (RD or developmental dyslexia) and
specific language impairment (SLI) are two of the most
prevalent neurodevelopmental disorders, with a prevalence
of ≈5–8 % among school-aged children (as reviewed in
[1–3]). Both RD and SLI are multifactorial disorders
with moderate to high heritabilities and are characterized
by high comorbidity, also with other neurodevelopmental
disorders such as attention deficit hyperactivity disorder
(ADHD) and speech sound disorders (SSD) [2, 4, 5]. It is
likely that RD and SLI, as well as the underlying reading-
and language-related skills, share some genetic/neurobio-
logical mechanisms [6, 7].
Candidate genes that have been implicated in reading-
and language-related traits include DYX1C1 (15q21),
KIAA0319 and DCDC2 (6p22), MRPL19/GCFC2 (2p12),
ROBO1 (3p12), CNTNAP2 (7q35), CMIP and ATP2C2
(16q23-24), and FOXP2 (7q31) (see [8–10] for reviews).
More recently, genome-wide association scans (GWAS)
using measures of both reading and language have re-
ported suggestive associations in ABCC13 (21q11.2),
DAZAP1 (19p13.3), ZNF385D (3p24.3), FLNC (7q32.1),
and RBFOX2 (as reviewed in [10]). Several of these candi-
date genes are known to have roles in important processes
in central nervous system (CNS) development, such as
neuronal migration, axonal guidance, and neurite out-
growth [8]. Moreover, a link with steroid hormone-related
biology has also been hypothesized (see [11] for further
details).
In these genes, most of the variants that have been
tentatively associated with reading and/or language traits
are single-nucleotide polymorphisms (SNPs), although
other types of genetic variants have also been implicated.
These include balanced translocations disrupting ROBO1
[12] and DYX1C1 [13] in dyslexic cases and translocations
and deletions affecting FOXP2 in a severe form of speech
and language disorder, involving childhood apraxia of
speech (CAS) [14].
The putative genetic associations reported so far can
explain only a small proportion of heritable variance in
reading and language skills [1, 4, 10]. Part of the “miss-
ing heritability” may be represented by Copy Number
Variants, defined as structural variations in the genome
that result in regions larger than 1 kb showing a non-
diploid copy number. Several copy number variants
(CNVs) have been identified in severe neurodevelopmental
and neuropsychiatric disorders, including schizophrenia
(SCZ), Autism Spectrum Disorders (ASD), Intellectual
Disability (ID) and Developmental Delay (DD) [15, 16].
However, only a few studies have focused on reading and/
or language impairments, which we review briefly here. In
the majority of these studies, a perfect co-segregation be-
tween CNVs and poor reading/language performance has
seldom been observed.
In a recent investigation on ten Indian dyslexic families,
de novo CNVs were identified at several loci, namely
GABARAP (17p13.1), NEGR1 (1p31.1), ACCN1 (17q11.21),
DCDC5 (11p14.1), and the known SLI candidate gene
CNTNAP2 (7q35) [17]. In the same families, candidate
susceptibility CNVs affecting the PCDH11X gene
(Xq21.31-q21.32) were also identified [18]. In a Dutch
family, Poelmans and colleagues [19] identified a het-
erozygous deletion in 21q22.3 co-segregating with RD
and encompassing the genes PCNT, DIP2A, S100B, and
PRMT2.
The largest study to date on CNVs in dyslexia involved
376 RD cases and 337 controls. Candidate susceptibility
CNVs were found, overlapping IMMP2L and AUTS2
(7q11.22) [20], a well-known ASD susceptibility locus.
With regard to language impairments, Wisznieski
et al. [21] identified a heterozygous deletion disrupting
the gene TM4SF20 (2q36), co-segregating with language
delay in 15 Southeast Asian families. In a CNV scan of
SLI families, a ~21-kb exonic microdeletion within ZNF277
(7q31.1, adjacent to the IMMP2L/DOCK4 locus) was found
[22]. A genome-wide CNV study comparing 127 independ-
ent SLI cases from the same dataset, together with first-
degree relatives and unrelated controls, reported novel
candidate de novo CNVs [23], disrupting the genes
ACTR2 (2p14), CSNK1A1 (5q33.1), and the regions typ-
ically involved in 22q11.2 and 8p23.1 duplication syn-
dromes. A recent CNV screen in a longitudinal cohort
of children with language-related difficulties or family risk
of dyslexia revealed a de novo deletion in 15q13.1–13.3,
observed in a child with persistent language impairment,
normal reading skills, and no evidence of sensory or
neurological problems [24]. This large heterozygous de-
letion had been previously reported in cases of broader
neurodevelopmental delay [24].
Other CNVs have been associated with poor reading
or language performance in the context of other comor-
bid disorders. A deletion disrupting both DOCK4 and
IMMP2L (7q31.1) was found to co-segregate with poor
reading performance in a family with two ASD cases,
and another DOCK4 exonic deletion co-segregated with
RD in a distinct dyslexic family [25]. Canonical 16p11.2
microdeletions—usually implicated in mild cognitive
impairment, general developmental delay, speech and
language problems, and ASD—have been associated
with CAS by independent studies [26, 27]. The same
microdeletion was hypothesized to act jointly with a
6q22.31 duplication in a subject with CAS and pervasive
developmental disorder [28]. Prader-Willi/Angelman
patients, presenting deletions/duplications of the 15q11.2
region, have been reported to frequently exhibit speech
and language delays [29]. Similarly, subjects with 2p15-
p16.1 microdeletion syndrome typically show cognitive,
linguistic, and psychiatric disabilities. In this region, a de
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novo deletion encompassing BCL11A has been implicated
in a mild phenotype characterized by apraxia, dysarthria,
and expressive language delay [30].
Recently, Stefansson and colleagues [31] investigated
the effect of several CNVs previously associated with
SCZ or ASD (hereafter called “neuropsychiatric CNVs”)
on different cognitive traits in a large Icelandic sample
(N~102,000). By comparing SCZ patients, neuropsychi-
atric CNV carriers, other CNV carriers, and general
population controls, they found that neuropsychiatric
CNV carriers performed at a level between SCZ patients
and controls on several psychometric tests, suggesting
an effect of these CNVs on general cognition. Some
neuropsychiatric CNVs showed association with cogni-
tive abilities: among these, 16p11.2del and 22q11.21dup
were associated with category and letter fluency, while
15q11.2del was associated with a history of dyslexia and
dyscalculia.
In the present study, we have further investigated the
potential influence of CNVs on reading and language
performance through a comprehensive set of analyses,
including total genome-wide CNV burden testing and
two complementary methods to screen the genome for
individual CNVs that may affect these traits. We used a
dataset that has been previously included in a SNP-
based GWAS meta-analysis (GWASMA) of reading and
language traits [11], composed of children recruited for
school history of RD or ADHD, and their unaffected
siblings.
Current CNV research in psychiatric genetics often relies
on case/control dichotomous classifications and seldom
detects perfect co-segregation between CNVs and disease
status. When heritable quantitative traits are available that
are strongly correlated with a dichotomous definition of a
disorder—as in the case of reading/language traits—-
analyzing the effect of putative CNVs directly on the quan-
titative trait provides an effective alternative to the analysis
of co-segregation between CNVs and the disorder. The
former analysis is aimed at detecting variants with reduced
penetrance and variable expressivity on traits of interest,
while the latter one is aimed at detecting variants with full
penetrance and expressivity. We used both approaches in
our study.
Methods
The experimental workflow of the present study, described
in this section, is summarized in Fig. 1. For simplicity, geno-
type and phenotype quality control (QC) are described
below in single paragraphs.
Dataset
The dataset analyzed in the present work was collected
in the Colorado Learning Disabilities Research Centre
(CLDRC) study, an ongoing research project on the eti-
ology of learning disabilities carried out in 27 school dis-
tricts in Colorado, USA [32]. Briefly, pairs of twins were
recruited for a school history of RD or ADHD in at least
one of the twins; they were then administered a number
of psychometric tests for several learning-related skills,
along with their additional co-siblings, and DNA was
collected for genetic studies. The Institutional Review
Boards of the University of Nebraska Medical Center
Fig. 1 Experimental workflow and dataset analyzed in the present study. (Single asterisk) As described in [11]. (Double asterisks) RD cases were
defined as samples in the lowest 10 % of IBGdiscr score distribution. (Triple asterisks) Legend of CNV states: “CNV+” corresponds to copyN≠ 2 (≠1 for X
chromosome probes in males); “CNV−” corresponds to copyN = 2 (=1 for X chromosome probes in males). See “GWAS with CNV state” section for
further details
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and of the University of Colorado at Boulder had ap-
proved the protocol, and written informed consent of
the participants (or their parents) was obtained.
For MZ twin pairs, we selected one child per pair
based on the maximum availability of reading- and
language-related trait data or otherwise randomly. The
sample of twins and siblings available for this study com-
prised 749 participants in total (mean age 11.7 years, age
range 8–19), from 343 unrelated twinships/sibships. Of
these, 266 of the twinships/sibships (a total of 585 par-
ticipants) were originally recruited via a proband with a
history of RD and 77 of the twinships/sibships (164 par-
ticipants in total) were originally recruited via a proband
with a history of ADHD. The two subsets are indicated
hereafter as CLDRC-RD and CLDRC-ADHD.
Reading and language measures
The reading- and language-related traits assessed in
CLDRC are reported in Table 1, and the relevant mea-
sures are described in detail elsewhere [11]. These traits
had been previously age-adjusted according to normative
data and further rank-normalized when a measure dif-
fered significantly from normality. Phenotypic outliers
were removed from the dataset, along with subjects with
full-scale IQ <70 (two participants in CLDRC-RD in
total). This left 564 subjects in CLDRC-RD and 163 in
CLDRC-ADHD. Then, samples underwent separate prin-
cipal component analyses (PCAs) in CLDRC-RD and in
CLDRC-ADHD for the computation of the first principal
component scores within each dataset, as briefly described
below (further details in [11]).
First principal component score
The first principal component (PC1) from all of the lan-
guage- and reading-related traits available (Table 1) was
derived in each dataset, through the SPSS® 20.0 Factor
Analysis. Only linear components with Eigenvalue >1
were extracted, allowing for correlation among the com-
ponents (oblique rotation) and excluding subjects with
any missing measure. PC1 explained 64.5 % of the total
variance in CLDRC-RD and 52 % in CLDRC-ADHD,
while PC2 explained no more than 13 % of the total
variance in both datasets. PC1 scores showed a broad
pattern of loadings across the traits in both datasets
(Table 1). To obtain a measure of shared variance in
reading and language skills independent of general cogni-
tive abilities, we also regressed PC1 against performance
IQ (which had not been included in PC1 computation),
again separately within the two datasets, and used the re-
siduals as IQ-adjusted PC1 scores (IQadjPC1).
IBG discriminant score
We also used an additional phenotypic trait, the IBG
discriminant score (called IBGdiscr hereafter), a dis-
criminant function empirically developed to diagnose
RD in the context of the CLDRC study [33]. This score
is a composite measure of word recognition, spelling, and
reading comprehension tests (further details available in
Additional file 1). For the purpose of the present study, we
used IBGdiscr to select all the participants in the first and
tenth decile of the score distribution (Additional file 1:
Figure S1a), namely all the subjects with a standardized
IBGdiscr <−1.4 (N = 67) and >2.2 (N = 69), as representa-
tive of poor and good reading performance, respectively.
Table 1 Phenotypic traits available and measures used for PC1 score derivation (labeled with relative loadings on PC1)
Trait Description (ability assessed) CLDRC-RD (564) CLDRC-ADHD (163)
WRead Reading real words 0.918 0.871
WSpell Spelling real words 0.813 0.764
PD Ability to convert letter strings into sounds, according to given phonetic rules 0.895, 0.861a 0.821, 0.729a
PA Ability to recognize and manipulate speech sounds (phonemes) 0.801 0.744
OC Ability to recognize a word as an orthographic unit and to retrieve the corresponding
phonological form
0.764 0.644
NWR Ability to repeat nonsense words orally presented 0.493 0.355
VIQ Verbal reasoning
PIQ Logical reasoning
PC1 Shared variance in reading and language skills 544 (528) 159 (155)
IQ-adjusted PC1 Shared variance in reading and language skills, not shared with performance IQ 544 (525) 159 (155)
Sample sizes of the datasets that underwent the PCA are reported in the header row. The number of samples for which PC1 score was computed are reported at
the bottom of the table (as we excluded participants with at least one missing measure among the traits involved in the PCA). These numbers still include LRR
outliers and samples discarded in CNV calling and QC process, which were filtered out for the specific purpose of this study, after extraction of PC1 scores. Final
sample sizes at the end of all QCs are reported in brackets.
WRead word reading, WSpell word spelling, PD phonological decoding, PA phoneme awareness, OC orthographic coding, NWR nonword repetition,
VIQ/PIQ verbal/performance IQ
aLoadings of nonword reading and phonological choice (respectively) on PC1s
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For simplicity, we indicate these subjects as “RD cases”
and “controls” in the analyses where a dichotomous case-
control classification was needed (see below).
Pairwise trait correlations of the reading and language
composite/component scores analyzed—computed as
median Pearson’s r coefficients over 100 repeat random
samplings of one individual from each unrelated
sibship—were high (r~0.83–0.98), both in CLDRC-RD
and in CLDRC-ADHD (see Additional file 1: Table S1).
DNA array data: generation and quality control
The two subsets were treated as a single dataset in DNA
data generation and QC, as previously described in our
GWAS meta-analysis [11]. DNA was extracted from
whole blood or buccal swab samples and prepared for
genotyping using standard protocols. DNA array data
were generated using Illumina® Human OmniExpress
array (730 k SNPs), and data were processed using Illumi-
na’s GenomeStudio® software, following the manufacturer’s
guidelines. QC and CNV calling process followed proce-
dures already used in previous CNV studies [23, 34, 35].
Samples with genotyping success rate <95 % were dis-
carded in GenomeStudio, along with probes mapping as
“0” (no position) and “Y” (Y chromosome) and probes with
call frequency <95 %. Using functions in the software
PLINK v1.07 [36], we filtered out samples which showed
inconsistencies in genome-wide identity-by-descent shar-
ing with their siblings and unrelated individuals, or sex
mismatches, or call rates <98 %, as well as homozygosity
outliers, as described elsewhere [11].
As a further QC step for this study, we ran a PCA on
the log R ratio (LRR) intensity signals of the 723,002
probes passing QC, through the pca command (singular
value decomposition method) in the pcaMethod R pack-
age [37], extracting the first 100 principal components.
This allowed us to assess the absence of extreme batch
effects among the different plates of the microarray and
to detect and remove 14 LRR outliers (Additional file 1:
Figure S1d), which left 713 subjects for subsequent
analysis.
CNV calls
To detect CNVs, we applied PennCNV (version June
2011) [38] separately for autosomes and the X chromo-
some (704,855 and 18,147 SNPs, respectively), analyzing
the two subsets jointly (N = 713). For this analysis, we
built a custom population B allele frequency (PBF) file
from our array intensity data through the compile_pfb.pl
script in PennCNV, while default HMM parameters and
GC model signal adjustment file were used. In order to
obtain highly reliable CNV calls, we applied a series of
filters to the CNV events initially called through the
detect_cnv.pl script: only putative CNVs with a minimum
confidence score of 10, covering at least 20 kb and 10
consecutive SNPs and showing limited overlap (<50 %)
with Ig regions, pseudo-autosomal regions (PARs),
centromeres, or other large genomic gaps were se-
lected. Moreover, to ensure only high quality of sam-
ples, we filtered out samples showing an excessive
number of CNV calls (>100 autosomal CNVs per sample)
and LRR standard deviation >0.35. All the other parame-
ters for sample filtering were set to default. Close CNVs
were joined when the gap separating them was ≤20 % of
the total length of the region that they covered. CNVs
passing QC were finally annotated to RefSeq genes, within
50 kb beyond the 5′- and 3′-untranslated regions (UTRs),
to include CNVs overlapping potential regulatory regions.
Similarly, we annotated CNVs overlapping exons, and we
identified a subset of “rare” CNVs, defined as CNV calls
showing overlaps with less than five CNV events reported
in the Database of Genomic Variants (DGV, July 2013 re-
lease, hg19). At the end of this process, we had 4490 final
CNV calls for 702 samples, of which 3344 were annotated
to genes, 2542 to exons, and 872 were rare.
Interpretation of CNVs and general statistics
The samples passing PennCNV QC (N = 702) were
tested for correlation between their CNV burden—both
in terms of total length and of total number of CNV
events per sample—and our continuous traits of interest,
namely PC1 and IQadjPC1, separately in the two subsets.
This analysis was applied to 525 PC1/IQadjPC1 scores
available in CLDRC-RD and to 155 scores available in
CLDRC-ADHD. We repeated the same analysis on CNVs
annotated to genes, on CNVs annotated to exons, and on
rare CNVs (defined as above). Similarly, we analyzed cor-
relations by length class, i.e., for short calls (<100 kb),
medium calls (≥100 and ≤500 kb), and large calls
(>500 kb) separately. To generate correlations unbiased
by non-normality of CNV burden measures and by sample
relatedness, rho correlation coefficients were calculated as
the median rho over 100 repeat random samplings of one
individual from each unrelated sibship, in R [39].
For the same classes of CNVs analyzed above (all, an-
notated and rare CNVs), we carried out a case-control
burden analysis on 67 RD cases and 69 controls as defined
above, through logistic regression of binary affection status
versus CNV burden measures, over repeat random sam-
plings of one individual from each unrelated sibship.
The final annotated CNVs were also assessed individually
for co-segregation with the “RD case” status, focusing on
large CNVs, on CNVs shared between two or more affected
co-siblings, on CNVs affecting genes previously implicated
in reading and language traits (see the “Background” sec-
tion) or overlapping with other neuropsychiatric CNVs
(previously tested by Stefansson et al. [31]).
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Genome-wide CNV association analyses of continuous
reading and language PC traits
GWAS with CNV state
CNV calls made in PennCNV were also used for a
genome-wide association test between CNV state at each
probe and PC1/IQadjPC1. The alternative CNV states at
each probe were “CNV-negative” (CNV−) when a probe
showed a diploid copy number, and “CNV-positive”
(CNV+) when it showed an abnormal copy number. In
other words, both deletions and duplications at each
probe were considered as a single CNV+ state.
We applied PLINK v1.07 QFAM analysis [36] to all
the 43,525 probes covered by CNV events (41,625
autosomal probes and 1900 X chromosome probes), in
CLDRC-RD (N = 525) and CLDRC-ADHD (N = 155)
separately.
In order to have a bi-allelic coding for probes involved
in this analysis, which indicated the presence or absence
of a non-diploid state, proxy genotypes were created
in the .ped input files. These were coded as “11” when
the probes were not covered by any CNV (i.e., copy
number =2) and as “12” when they fell within CNV
calls (i.e., copy number ≠ 2). For chromosome X, CNV
states per probe were coded as “11” for probes with
copy number =1 and “12” for probes with copy num-
ber ≠1 in males, while they were coded following the
rules of autosomal CNV state in females. Then, X
chromosome probes were tested for association separately
within males and females and later meta-analyzed. To cor-
rect for non-independence of siblings, permutations were
run in QFAM analysis, as previously described in [11].
After QFAM analysis, the results of separate GWAS for
CLDRC-RD and CLDRC-ADHD were meta-analyzed
using the METAL software package, through the sample-
size-based scheme [40]. Results were then interpreted in
terms of consecutive probes showing significant associa-
tions (i.e., at least two consecutive probes with p < 0.005 at
the genome-wide level and contiguous with two or more
probes with p < 0.05), representing regions of overlap of
two or more CNVs with potential effects on the continu-
ous traits investigated.
GWAS with intensity data
As a complementary analysis, we tested for association
of LRR and BAF (beta allele frequency) intensity data
from our DNA array with PC1 and IQadjPC1, applying
FamCNV 2.0 [41] (beta version available upon request
to Dr. Mario Falchi).
In this analysis, we tested for association of 704,855
autosomal probes passing QC in CLDRC-RD (N = 525)
and in CLDRC-ADHD (N = 155), using as covariates the
first and second principal components computed in the
PCA of LRR data (see the “DNA array data: generation
and quality control” section). After running separate
GWAS in the two subsets, the results were meta-
analyzed as above, using rho correlation coefficients be-
tween LRR data and PC1/IQadjPC1 as beta values at
each probe, indicative of the direction of association. Re-
sults were interpreted in terms of contiguous probes
showing significant associations (i.e., pairs of consecutive
probes with p < 0.001 and contiguous with two or more
probes with p < 0.05), which were more likely to repre-
sent real CNV effects.
Pathway-based analysis of CNV calls
To test specific molecular networks for enrichment of
potentially disrupting CNVs, we ran a pathway-based as-
sociation analysis in INRICH v1.0, through the TARGET
algorithm [42]. This tool tests groups of independent
genomic intervals for enrichment of overlaps with pre-
defined gene sets, through a permutation-based ap-
proach. We initially tested 306 CNVs called in 67 RD
cases, and then we restricted the analysis to 84 rare
CNVs in the same subset.
Gene boundaries in the tested gene sets were again de-
fined as extending 50 kb beyond the 5′- and 3′-UTRs,
while random genomic intervals simulated in the per-
mutations of the test were extracted from a reduced set
of 43,525 SNPs, namely all the probes encompassed by
CNV calls. We considered testing CNV calls more suit-
able than testing associated genomic intervals as pro-
duced by GWAS analyses, since such intervals would
need to be defined on an LD basis, which is clearly in-
appropriate for the analysis of CNVs.
Initially, we tested three candidate gene lists for en-
richment, based on the gene sets of the Gene Ontology
Database (http://www.geneontology.org/). These gene sets
represented three distinct neurobiological hypotheses on
the etiology of RD (see the “Background” section): axon
guidance (including all the GO sets containing the term
“axon guidance”), neuronal migration (including all the
GO sets containing the term “neuron migration”), and sex
hormone biology (including all the GO sets containing the
terms “steroid,” “androgen,” “estrogen,” “progesterone,”
and “testosterone”). Then, we extended the assessment to
1748 GO sets containing at least 10 genes, for exploratory
purposes.
Results
CNV calls
General CNV burden statistics
After QC, there were 4490 final CNV calls in 702 sam-
ples, of which 3344 were annotated to genes within a
50-kb interval from the UTRs, 2542 were annotated
within exonic borders, and 872 were rare. Samples pass-
ing QC showed a median number of 6 CNVs per sample
(4 considering only CNVs annotated to genes) and a
median total length of ~640 kb covered by CNVs per
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sample (~479 kb considering only CNVs annotated to
genes).
Correlation assessments between CNV burden measures
(both CNV number and total length) and our continuous
traits of interest—PC1 and IQadjPC1—did not reveal any
significant correlation in the two CLDRC subsets, when
considering all the CNVs passing QC (most significant cor-
relation rho~−0.097, p = 0.4) or when considering only
CNVs annotated to genes or to exons (most significant cor-
relation rho~−0.036, p = 0.51). Similarly, burden analysis by
length class (applied to all CNVs passing QC) did not show
any significant correlation (most significant correlation
rho~−0.17, p = 0.13, detected for short CNVs). We also
tested correlation using burden statistics of rare CNVs
called in our dataset, but again found no significant correl-
ation with principal component (PC) scores (most signifi-
cant correlation rho~−0.15, p = 0.2). Finally, case-control
burden analysis comparing 67 RD cases and 69 controls
did not reveal any significant association with CNV burden
statistics (data not shown).
Large CNVs
Large CNVs are more likely to span multiple genes and
to have deleterious effects than smaller CNVs. Among
CNVs spanning more than 500 kb in RD cases (Table 2,
see Additional file 2: Table S2a for further details), a
heterozygous duplication was detected in two affected
siblings, but not in their unaffected co-sibling (with
IBGdiscr = −0.62, PC1 = −0.47, and IQadjPC1 = 0.42).
This large CNV spanned ~1.2 Mb in the pericentromeric
region 11q11-q12.1, covering several OR genes (encoding
olfactory receptors) and TRIM genes (encoding tripartite
motif proteins).
CNVs shared between RD cases
Among all the sibships analyzed, ten presented more
than one RD case. In these sibships, we assessed anno-
tated CNVs which were detected in two or more affected
co-siblings but in no unaffected participant, regardless of
their length. We investigated these variants as they were
more likely to confer genetic susceptibility to reading
impairment, compared to CNVs presented by single
cases. A total of three CNV events fell in this category
(Table 3, see Additional file 2: Table S2b for further de-
tails), including the large duplication mentioned above
and other two CNV events.
In a family presenting two affected siblings but no un-
affected co-siblings, we detected two shared CNVs (both
heterozygous duplications), which were not detected in any
other participant in the study. One of them, spanning
~27 kb on 6q24.2, covered the last nine exons (66–74) in
the 3′ terminal region of the UTRN (utrophin) gene, in-
cluding its 3′-UTR. The other one spanned ~63 kb and
overlapped exons 38–49 within DNAH14 (dynein axo-
nemal heavy chain 14) on 1q42.12.
CNVs in genes previously associated with reading and
language traits
We identified three putative CNVs annotated to candidate
susceptibility genes that have been implicated in reading
and language traits by more than one study (see [8–10]
for reviews). These CNVs are reported in Additional file 2:
Table S2c. Among the candidate genes assessed, DYX1C1
and CNTNAP2 were overlapped by one or more of these
CNVs. However, only one of the three participants show-
ing these variants was impaired and none of these CNVs
co-segregated with poor reading-language performance
(Additional file 2: Table S2c).
Similarly, we detected four CNV calls overlapping
genes in which suggestive associations were observed in
previous GWAS studies of both reading and language
skills (reviewed in [10]). A list of these CNVs is reported
in Additional file 2: Table S2d. Again, none of these
variants co-segregated with RD status or with poor
reading-language performance.
CNVs previously associated with weak reading/language
performance and common neuropsychiatric CNVs
We checked our CNV calls for overlaps with genes and
regions previously found to be disrupted by CNVs in
subjects with weak reading/language performance (see
the “Background” section). Additional file 2: Table S2e
reports these CNVs, which were detected in NEGR1,
IMMP2L, PCDH11X, CNTNAP2, CSNK1A1, MSRA
(8p23.1), UBASH3B, CACNA2D1, VWA3B, CXorf22,
CHRNA7 (15q13.1), and in several genes in the 22q11.21
region. As before, none of these variants showed co-
segregation with RD or poor reading-language perform-
ance in the sibships.
Similarly, we assessed overlaps with common neuro-
psychiatric CNVs recently tested by Stefansson and col-
leagues [31] for effects on several cognitive traits in a
large sample of the Icelandic population. Additional file
2: Table S2f reports a list of canonical CNVs detected in
our study (i.e., largely or completely overlapping the
abovementioned neuropsychiatric CNVs, reported in
Table S1 in [31]). Among these CNV events, a 1.33-Mb
heterozygous duplication in 16p13.11 was detected in an
affected participant, who had the lowest phenotypic
scores in his sibship and exhibited strong score dis-
crepancies with his co-sibling (>3 for IBGdiscr and
PC1 and >2.6 for IQadjPC1). However, a similar dupli-
cation was present in an unrelated participant showing
normal performance, with PC1 and IQadjPC1 scores
higher than those of his sibling (data not shown). None of
the other carriers of such canonical neuropsychiatric
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Table 2 Large annotated CNV events (>500 kb) detected in RD cases
Subject Family Chr Start (kb) End (kb) SNPs Length (kb) CopyN Frequency Gene PC1 IQadjPC1 IBGdiscr
IBG143157 3914 2 96,196 96,737 26 541 3 Common FAHD2CP,GPAT2,LINC00342,TRIM43 −2.51 −2.59 −3.29
IBG112039 3576 11 48,397 48,943 33 546 1 Common OR4A47 −0.59 −0.43 −1.76
IBG1448951 4442 14 19,848 20,420 17 573 3 Common 10 genes (including several OR genes)a −0.97 −1.05 −2.83
IBG143577 4010 2 132,731 133,354 120 622 3 Common ANKRD30BL,GPR39,MIR663B −1.73 −1.54 −2.09
IBG112079 3906 8 105,737 106,407 147 670 3 Rare ZFPM2 −1.56 −1.65 −1.98
IBG111829 2856 11 49,770 50,283 44 513 3 Common LOC440040,LOC441601,OR4C12,OR4C13 −1.93 −1.74 −2.78
IBG112389 4048 5 45,672 46,399 35 727 3 Common HCN1 −1.47 −1.57 −3.18
IBG145160 4499 11 54,794 56,004 190 1209 3 Common 30 genes (including several OR and TRIM genes)b −2.21 −2.05 −3.63
IBG1451651 4499 11 54,794 56,004 190 1209 3 Common 30 genes (including several OR and TRIM genes)b −1.83 −1.74 −2.14
IBG111948 3523 16 14,975 16,303 419 1328 3 Common 27 genes (including several microRNAs)c −1.55 −1.53 −1.61
When a CNV is annotated to more than five RefSeq genes, these are reported in a footnote (see below). All the CNVs partially overlapped or encompassed the genes to which they were annotated. All the positions
are expressed in hg19 coordinates. The frequency column specifies how each CNV call showed substantial overlaps (≥50 %) with any CNV reported in the DGV database (July 2013, hg19): ≥5 overlaps for common
CNVs, <5 overlaps for rare CNVs. An extended format of this table including further details is available in Additional file 2: Table S2a)
aBMS1P17, BMS1P18, OR11H2, OR4K1, OR4K2, OR4K5, OR4M1, OR4N2, OR4Q3, POTEM
bOR10AG1, OR4A15, OR4A16, OR4C11, OR4C15, OR4C16, OR4C6, OR4P4, OR4S2, OR5AS1, OR5D13, OR5D14, OR5D16, OR5D18, OR5F1, OR5I1, OR5J2, OR5L1, OR5L2, OR5T2, OR5W2, OR7E5P, OR8H2, OR8H3, OR8I2,
OR8J3, OR8K5, TRIM48, TRIM51, TRIM51HP
cABCC1, ABCC6, C16orf45, FOPNL, KIAA0430, LOC100288162, MIR3179-1, MIR3179-2, MIR3179-3, MIR3180-1, MIR3180-2, MIR3180-3, MIR3180-4, MIR484, MIR6506, MIR6511A-2, MIR6511B-1, MIR6770-2, MPV17L, MYH11,
NDE1, NOMO1, NPIPA1, NPIPA5, NTAN1, PDXDC1, RRN3
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CNVs were RD cases, based on IBGdiscr performance (see
Additional file 2: Table S2f).
When two or more CNV calls were overlapping in
these regions, the encompassed probes were assessed in
PLINK QFAM analysis of CNV state to detect stretches of
consecutive probes associated with PC1 and IQadjPC1
scores.
Family-based GWAS of principal component scores
Association test with CNV state at each probe
GWAS meta-analysis testing association between CNV
state at each probe and PC1/IQadjPC1 did not report
any significant association surviving correction for mul-
tiple testing of two traits and 5173 autosomal probes
meta-analyzed (α = 4.8 × 10−6), representing all the
probes encompassed by at least one putative CNV event
in both our subsets. None of the 1900 X chromosome
probes lay within CNV events detected in participants of
both sexes and in both CLDRC subsets; therefore, none
of these probes was meta-analyzed. The results of this
analysis on an individual probe basis are reported in
Additional file 3: Tables S3a, b. No genome-wide signifi-
cant association was detected in either of the two subsets
analyzed (data not shown).
These results were interpreted in terms of consecutive
probes showing significant associations with PC1 and/
or IQadjPC1 (i.e., at least two consecutive probes with
p < 0.005 and contiguous with two or more probes with
p < 0.05), in regions of overlap of two or more CNVs in
our dataset (Table 4). All of the top associated regions
showed nominally significant associations both with PC1
and IQadjPC1 (p values in the range [0.001; 0.05]), with the
exception of chr3:2,663,757-2,675,189 (p values~[0.096;
0.245] in PC1 meta-analysis). All of these regions over-
lapped with genes: chr3:2,663,757-2,675,189 lay within
CNTN4 (contactin 4, 3p26.3; Additional file 3: Figure S3a);
chr6:168,336,080-168,597,552 partially overlapped MLLT4
(myeloid/lymphoid or mixed-lineage leukemia translocated
to, 4) and encompassed the genes KIF25 (kinesin family
member 25), FRMD1 (FERM domain containing 1), KIF5-
AS1 (KIF25 antisense RNA 1), and GCH6.3 (uncharacter-
ized protein) on 6q27 (Additional file 3: Figure S3b);
Table 3 Annotated CNVs shared between two or more affected co-siblings in ten families presenting more than one RD case, which
were not detected in any unaffected participant
Subject Family Chr Start (kb) End (kb) SNPs Length (kb) CopyN Frequency Gene PC1 IQadjPC1 IBGdiscr
IBG145160 4499 11 54,794 56,004 190 1209 3 Common 30 genes (including several OR
and TRIM genes)a
−2.21 −2.05 −3.63
IBG1451651 4499 11 54,794 56,004 190 1209 3 Common 30 genes (including several OR
and TRIM genes)a
−1.83 −1.74 −2.14
IBG142799 3514 6 145,148 145,175 15 27 3 Rare UTRN −1.62 −1.35 −2.12
IBG142797 3514 6 145,148 145,175 15 27 3 Rare UTRN −1.84 −2 −1.66
IBG142799 3514 1 225,391 225,454 14 63 3 Common DNAH14 −1.62 −1.35 −2.12
IBG142797 3514 1 225,391 225,454 14 63 3 common DNAH14 −1.84 −2 −1.66
When a CNV is annotated to more than five RefSeq genes, these are reported in a footnote (see below). All the CNVs partially overlapped or encompassed the
genes to which they were annotated. All the positions are expressed in hg19 coordinates. The frequency column specifies how each CNV call showed substantial
overlaps (≥50 %) with any CNV reported in the DGV database (July 2013, hg19): ≥5 overlaps for common CNVs, <5 overlaps for rare CNVs. An extended format of
this table including further details is available in Additional file 2: Table S2b
aOR10AG1, OR4A15, OR4A16, OR4C11, OR4C15, OR4C16, OR4C6, OR4P4, OR4S2, OR5AS1, OR5D13, OR5D14, OR5D16, OR5D18, OR5F1, OR5I1, OR5J2, OR5L1, OR5L2,
OR5T2, OR5W2, OR7E5P, OR8H2, OR8H3, OR8I2, OR8J3, OR8K5, TRIM48, TRIM51, TRIM51HP
Table 4 Regions of CNV overlap showing the most significant associations with PC1/IQadjPC1 in the GWAS meta-analysis with CNV
state (PLINK QFAM)
Chr Start (bp) Stop (bp) Kb SNPs p value (PC1) p value (IQadjPC1) Effecta Frequency (%)b Genec
3 2,663,757 2,675,189 11 13 [0.096; 0.245] [0.003; 0.014] + 0.4–0.6 CNTN4
6 168,336,080 168,597,552 261 130 [0.005; 0.176] [0.001; 0.035] − 1.7–3.4 MLLT4, KIF25, KIF25-AS1, HGC6.3, FRMD1
10 68,221,549 68,242,672 21 10 [0.015; 0.022] [0.004; 0.007] − 0.4 CTNNA3
11 55,241,556 55,362,955 121 28 [0.005; 0.013] [0.002; 0.005] − 0.4 OR4C15, OR4C16
All the regions of overlap of two or more CNVs, showing at least two consecutive probes with association p < 0.005 and two or more contiguous probes with
association p < 0.05, are reported. The results of this meta-analysis on an individual probe basis are reported in detail in Additional file 3: Table S3a, b. All the
positions are expressed in hg19 coordinates
aEffect of the CNV+ state, irrespective of the copy number, on PC1 and IQadjPC1
bFrequency (%) of the CNV+ state in the CLDRC dataset
cRefseq genes overlapped/encompassed by the region reported. None of these regions annotated to potentially regulatory elements in the genome, such as
transcription factor binding sites, digital DNase I hypersensitivity clusters, and H3K27Ac histone marks, as collected in ENCODE tracks. Similarly, no annotation was
detected to the most conserved genomic regions in the primate clade (PhastCons 46-way elements), nor to the most positively selected regions since Homo
Sapiens-Neanderthal split (i.e., regions showing S scores from Selective Sweep Scan track in the lower 5 %). All the tracks used here are available for download
from the UCSC table browser (http://genome.ucsc.edu/cgi-bin/hgTables)
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chr10:68,221,549-68,242,672 lay within CTNNA3 (catenin
alpha 3, 10q21.3; Additional file 3: Figure S3c); and
chr11:55,241,556-55,362,955 encompassed genes OR4C15
and OR4C16 (olfactory receptors 15 and 16, family 4, sub-
family C, 11q11; Additional file 3: Figure S3d). Frequency of
CNV+ state in these regions ranged between 0.4 and 3.4 %.
We also checked the presence of nominally significant
associations (i.e., at least two consecutive probes with p <
0.05) in the regions disrupted by CNVs in cases of reading,
language, or more severe neuropsychiatric disorders (see
the “Background” section). If CNV events in any of these
regions had been called only in one of the subsets and
therefore meta-analysis had not been run for the probes
encompassed, we assessed directly the GWAS results in
the relevant subset. Among the candidate CNVs assessed, a
~134-kb region (chr15:32,380,064-32,514,341) partially
overlapping CHRNA7 (cholinergic nicotinic receptor
alpha 7, 15q13.3; Fig. 2) showed a series of 25 consecu-
tive probes associated with PC1 (p values~[0.026;
0.045], Additional file 3: Table S3e). These associations
were detected in CLDRC-RD as no CNVs were called in
the CLDRC-ADHD subset and were not significant in the
IQadjPC1 GWAS (p values~[0.053; 0.085]). This region
showed a frequency of CNV+ state of ~1.8 % (see Add-
itional file 2: Table S2e for relevant CNV calls) and a
positive allelic trend between the CNV+ state and PC1/
IQadjPC1 (see Additional file 3: Table S3e).
Association test with probe intensity data
GWAS meta-analysis of PC1/IQadjPC1 scores with inten-
sity data (FamCNV) did not reveal any genome-wide sig-
nificant association surviving correction for multiple
testing of 704,855 autosomal probes and two traits meta-
analyzed (α = 3.6 × 10−8). The results of this analysis on an
individual probe basis are reported in Additional file 3: Ta-
bles S3c, d. No genome-wide significant association was
detected in the two subsets analyzed (data not shown).
Also for this analysis, we were interested in detecting
two or more consecutive probes showing significant
association. For this purpose, we filtered our association
results to detect all the pairs of consecutive probes with
p < 0.001 and contiguous with two or more probes with
p < 0.05. Such criteria were set to reduce the probability
to observe spurious associations due to noise intrinsic to
raw intensity data. Although we did not find any region
meeting these criteria in the results of the meta-analysis,
we found such a region in the GWAS in CLDRC-RD.
This ~58-kb region (chr19:20,657,781-20,715,228) con-
sisted of eight consecutive SNPs on 19p12, associated
with both PC1 (top consecutive hits rs2021399 and
rs2545918, p = 6 × 10−4 and 4 × 10−4, respectively) and
IQadjPC1 (p = 2 × 10−4 and 9 × 10−4; see Additional file
3: Table S3f). This region lay within a ~80-kb deletion
that was frequent in our dataset (called in 11.3 % of
CLDRC participants, for a total of 80 CNV calls, re-
ported in Additional file 2: Table S2g) and ~6-kb
downstream of ZNF737 (zinc finger protein 737,
Fig. 3). The same region of overlap also showed nom-
inally significant association (p values~[0.009; 0.022])
in the PLINK QFAM analysis with CNV state, in a
wider interval (chr19:20,626,179-20,715,228, see Fig. 3
and Additional file 3: Table S3g). Both in the associ-
ation test with SNP intensity data and in the associ-
ation test with CNV state, this deletion showed a
positive effect on PC1/IQadjPC1.
Pathway-based analysis of CNV calls
Pathway association analysis of 306 CNV calls presented
by 67 RD cases did not reveal any significant enrich-
ment, neither in the analysis of three composite candi-
date pathways representing neuronal migration, axonal
guidance, and steroids-related processes (Additional file
3: Table S3h), nor in an exploratory analysis at the
pathway-wide level (data not shown). Similarly, we did
not observe any significant enrichment in the analysis of
84 rare CNVs detected in RD cases (see Additional file
3: Table S3i for results on candidate pathways).
Fig. 2 Candidate region of CNV overlap associated with PC1 in the GWAS with CNV state. The red line indicates the associated interval
chr15:32,380,064-32,514,341, partially overlapping CHRNA7 (15q13.3). Black horizontal lines represent the individual CNV calls detected in this
region (nine heterozygous duplications and one heterozygous deletion; see Additional file 2: Table S2e for details)
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Discussion
Our research on potential effects of CNVs on reading
and language is novel for two main reasons:
First, we investigated the effects of CNVs on a con-
tinuous index of reading and language performance, in
datasets enriched for the lower tail of the population
distribution. Although a similar approach was used in a
recent study by Stefansson and colleagues [31], who inves-
tigated the effect of candidate neuropsychiatric CNVs on
cognitive traits in a large sample of the Icelandic popula-
tion, their study analyzed a broad spectrum of cognitive
abilities and included general population controls. It was
not aimed at capturing shared variation derived from a
detailed battery of reading and language measures in a
selected population, as was our study.
Second, to detect effects of CNVs on continuous reading
and language performance, we used two complementary
approaches: one aimed at detecting copy number-
dependent effects in a “dosage-dependent” additive model
and one aimed at detecting associations with a “CNV-
positive” state irrespective of the non-diploid copy
number. These two analyses were performed in order
to identify potential CNVs with reduced penetrance
and variable expressivity and were in turn complemen-
tary to our analysis of co-segregation between CNVs
and RD status, which was aimed at detecting variants
with high penetrance and expressivity.
In our dataset of subjects with school histories of RD/
ADHD and their siblings, we did not identify a signifi-
cant correlation between CNV genomic burden—both in
terms of total length and of total number of CNVs per
subject—and PC scores representing reading-language
performance. Similarly, our case-control burden analysis
did not reveal any significant contribution of CNVs to
RD. This is in line with a previous study which detected
no significant difference in the genomic burden of large
rare CNVs between RD cases and controls [20]. How-
ever, our result is in partial contrast with a recent study
which reported an increased CNV burden in SLI cases
compared to controls [23]. On balance, it appears likely
that CNVs have a relatively limited role in affecting
reading-related performance at the population level,
whereas they are known to play a more important role
in severe neuropsychiatric disorders such as autism,
schizophrenia, and ID [15, 16, 20] and may also affect
severe cases of SLI. Further analyses in independent
datasets will be needed to clarify the extent to which
CNVs may affect cognitive domains that are shared be-
tween reading and language.
In this study, we detected a CNV which co-segregated
with the dyslexic status in a family with two RD cases—
including the most severely impaired subject in our
dataset—and one unaffected sibling. This large CNV
event spanned ~1.2 Mb in the pericentromeric region
11q11-q12.1, covering several OR (olfactory receptors)
and TRIM (tripartite motif protein) genes. While TRIM
proteins are not well characterized, the role of olfactory
receptors in triggering odor perception signals in sensory
neurons is well known. Interestingly, olfactory bulbs dys-
genesis/agenesis has been previously implicated in ASD
[43] and reduced volumes have been reported in schizo-
phrenic patients [44]. However, the partial overlap of this
CNV with a centromeric region and the relaxed selec-
tion at the OR loci [45] suggest caution in the biological
interpretation of this variant.
Two other CNVs shared between cases were detected,
overlapping potential susceptibility genes. These two
heterozygous duplications were observed in a pair of af-
fected siblings but were not detected in any unaffected
participant. One of them overlapped 9 exons in the 3′
terminal region of the UTRN gene (utrophin, or
dystrophin-related protein 1, 6q24.2) and the other one
overlapped 12 exons within DNAH14 (dynein axonemal
heavy chain 14, 1q42.12). Utrophin is a large skeletal
muscle protein—also expressed in the CNS—contributing
to postsynaptic membrane maintenance and to clustering
of acetylcholine receptors in the neuromuscular synapses
and possibly playing a role in anchoring the cytoskeleton
to the plasma membrane. However, as the partial duplica-
tion of UTRN overlaps its 3′-UTR region, it is possible
that this has no effect on the mRNA produced. This possi-
bility may be addressed through future gene functional
analysis. Dyneins are microtubule-associated motor pro-
teins with a key role in cilia-mediated cell motility.
Fig. 3 19p12 region associated with PC traits in the GWAS with probe intensity data. The blue line indicates the interval of association with probe
intensity data (chr19:20,657,781-20,715,228), while the red line indicates the overlapping region of association between CNV state and PC scores
(chr19:20,626,179-20,715,228). Black horizontal lines represent the three types of deletions detected in this region (reported in Additional file 2:
Table S2g)
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Independent studies have reported evidence of involve-
ment in cilia-related processes for two RD candidate
genes, DYX1C1 [46, 47] and DCDC2 [48]. This led to the
hypothesis that dyslexia may sometimes be a form of cilio-
pathy [46], involving abnormal neuronal development and
migration [48].
Pathway-based enrichment testing of CNV calls de-
tected in RD cases revealed no significant associations
for three candidate gene sets representing mainstream
hypotheses on the etiology of RD, namely axon guid-
ance, neuron migration, and steroids-related processes.
This is in line with the pathway enrichment test based
on SNP associations in an earlier GWASMA study
that we carried out [11].
The two complementary strategies for genome-wide
association testing between CNVs and our principal
component reading-language scores revealed partly
different but partly consistent results. The first of these
analyses—which made use of CNV calls and tested as-
sociation with CNV state at each probe—was aimed at
detecting associations in regions of overlap of CNV
calls, irrespective of the abnormal copy number state.
The second analysis, in FamCNV, assessed copy number
(or allele dosage)-dependent associations between DNA
array intensity data and PC1/IQadjPC1. These are prac-
tical strategies to detect different kinds of effects of CNVs
on continuous traits, both of which have precedence in
the literature: in recent studies, copy number-dependent
(dosage) effects were reported for continuous traits such
as body mass index [49] and structural brain measures
[31]; while either deletions or reciprocal duplications of
specific regions have been reported to result in similar
clinical and phenotypic manifestations, as in the case of
ASD, language/developmental delays, and other psychi-
atric disorders [15, 16]. Both analyses were run probe-
by-probe, but results were then interpreted in terms of
consecutive probes showing significant associations,
which was appropriate for an analysis of CNVs.
Although no associations reached genome-wide signifi-
cance in PLINK QFAM meta-analysis, some of the top
associated regions involve plausible candidate genes. A
~11-kb CNV overlap, associated with IQadjPC1, lay in an
intronic region within CNTN4 (contactin 4, 3p26.3; Add-
itional file 3: Figure S3a). This overlap was shared by three
heterozygous duplications and one heterozygous deletion,
which all showed concordant positive effects on PC
scores. Contactins are Ig cell adhesion molecules with a
fundamental role in neuronal development and plasticity.
CNVs and structural rearrangements disrupting CNTN4
have been implicated in severe neurodevelopmental
disorders such as ASD [50, 51] and DD [52]. Interest-
ingly, the associated region detected in the present
study overlaps with CNVs reported in ASD cases in
two previous studies [50, 51], and contactin 4 is widely
expressed in the brain, particularly in the cerebellum,
thalamus, amygdala, and cerebral cortex [50]. However,
this association was weaker and not significant with PC1.
Another intronic CNV overlap region of ~21 kb, asso-
ciated with both PC1 and IQadjPC1, was found within
CTNNA3 (catenin alpha 3, 10q21.3; Additional file 3:
Figure S3c). This region resulted from the overlap of
three deletions and showed a negative effect on PC
scores. α-catenins have a crucial role in cell adhesion,
and CTNNA3 has been implicated in ASD etiology
through both CNV studies [53, 54] and GWAS studies
[55, 56]. Our associated region partially overlaps an
inherited compound heterozygous deletion encompass-
ing exon 11, found in an ASD patient [53]. Expression of
CTNNA3 in mouse hippocampus and cortex at postnatal
day 0 suggests a specific neuronal role at very early de-
velopmental stages [53].
We also assessed CNV overlaps in regions previously
reported to be disrupted by CNVs in reading, language,
or more severe neuropsychiatric disorders. Among
these, a ~134-kb region of overlap between nine hetero-
zygous duplications and one heterozygous deletion,
encompassing several exons in the 3′ region of
CHRNA7 (cholinergic nicotinic receptor alpha 7,
15q13.3; Fig. 2), presented nominally significant associ-
ation with PC1 in the CLDRC-RD subset (while no
CNV calls were detected in CLDRC-ADHD). The asso-
ciation only approached significance after IQ adjust-
ment and the CNV state exerted a positive effect on
PC1/IQadjPC1, with both deletion and duplications
showing the same direction of effect. Nicotinic choliner-
gic receptors are ligand-gated ion channels that mediate
fast signal transmission at synapses and are ubiquitously
expressed in the CNS. Several studies have suggested a
possible involvement of CHRNA7 in language skills. A
CNV encompassing this gene was suggested to contrib-
ute to the disruption of synaptic pathways in a patient
with ID and language impairment [57]. A genome-wide
CNV screen also reported CHRNA7 among the genes
disrupted in a group of unrelated SLI cases, as well as a
significant over-representation of the GO category
acetylcholine binding in a pathway-based analysis of
these CNVs [23]. A recent longitudinal study of children
with language difficulties implicated a deletion at
15q13.1-13.3 (BP3-BP5) in the etiology of SLI, and the
authors hypothesized a role of CHRNA7 in the pheno-
typic effects associated to this region [24]. The 15q13.3
region is also a hotspot of neuropsychiatric CNVs,
which have been implicated in several disorders includ-
ing SCZ, ASD, ADHD, and epilepsy [15, 16]. CNVs
encompassing this gene have also been tested for effects
on general cognitive abilities, including school history
of mathematical and reading difficulties, but no associa-
tions were reported [31].
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Similarly to PLINK QFAM analysis, FamCNV
meta-analysis did not reveal any genome-wide sig-
nificant association. However, we found a series of
eight contiguous SNPs associated with both PC1
and IQadjPC1 in the CLDRC-RD analysis, ~6-kb
downstream of ZNF737 (zinc finger protein 737,
19p12, Fig. 3). This ~58-kb region lay within a ~80-kb
deletion which was common in our dataset, and the
association was also observed at the nominal signifi-
cance level in the PLINK QFAM analysis of CLDRC-
RD. Both FamCNV and QFAM analysis indicated a posi-
tive effect of this deletion on PC1/IQadjPC1. Zinc finger
protein 737 has not been functionally characterized, but
the presence of a zinc finger domain suggests a possible
involvement in transcriptional regulation. Interestingly,
a microdeletion within another zinc finger gene,
ZNF277, has been suggested as susceptibility CNV for
SLI [22].
In spite of the interesting suggestive associations
discussed above, the modest sample size and absence
of a replication sample constitute limitations for the
present study, and further analyses in larger datasets
are warranted. In addition, the localization of CNV
breakpoints and functional validation of candidate
CNVs can help to validate and extend such associa-
tions. Also, the definition of RD cases was necessarily
somewhat arbitrary (as in all studies). Nonetheless,
for completeness of our analysis, we used this ap-
proach to assess co-segregation with CNVs in the sib-
ships. As there is no universal agreement on the
diagnostic definition of dyslexia [1, 3], we used a
“performance only”-based criterion, classifying all the
participants in the lowest 10 % of the IBGdiscr score
distribution as RD cases and considering them as rep-
resentative of reading impairment. Finally, it may be
observed that many of the CNVs identified are in
CNV hotspot regions and they may represent benign
variants. Nonetheless, the fact that these CNVs are
frequently detected in the general population does
not rule out potentially modifying effects on reading
and language skills. For this reason, we did not ex-
clude CNVs present in the DGV from our analysis.
Conclusions
Overall, this study did not identify clear effects of CNVs
on reading and language performance, but identified a
number of putative, individual susceptibility factors in
the genome. We believe that applying the comprehen-
sive strategy used in this study to larger datasets may
facilitate the identification of new structural variants
involved in reading and language performance and re-
veal part of the missing heritability for reading and lan-
guage measures.
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